Multiorgan Failure

3

Review clinical trials related to Multiorgan Failure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study

This study aims to evaluate the clinical effectiveness of the oXiris® hemofilter in patients with septic shock and acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). While some studies suggest that oXiris® may improve hemodynamic stability by removing endotoxins and cytokines, its impact on survival remains inconsistent.To provide more reliable causal evidence, this multicenter retrospective cohort study utilizes a Target Trial Emulation (TTE) approach. The study will compare patients treated with the oXiris® filter to those treated with standard CRRT filters, focusing on in-hospital mortality and other clinical outcomes such as fluid balance and vasopressor requirements.

Participants needed: 360
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Seoul National University Bundang HospitalUpdated: Apr 20, 2026Locations: 1
Eligibility criteria

Adults aged 19 years or older. [+2]

Death or withdrawal of life-sustaining therapy within 48 hours of ICU admission. [+2]

Status: Recruiting

Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.

Low-level interventional clinical trial to evaluate the effectiveness and safety of extracorporeal support with hemoperfusion in critical patients with septic multiorgan dysfunction syndrome.

Participants needed: 48
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Hospital Clinic of BarcelonaUpdated: Jun 10, 2025Locations: 1
Eligibility criteria

Sepsis of abdominal origin with controlled infectious focus. [+6]

Age under 18 years or over 80 years. [+8]

Status: Recruiting

Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia

The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will be examined.

Participants needed: 200
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Osijek University HospitalUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Pneumonia caused by SARS-CoV-2 virus [+1]